The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179: 8137-8145.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Firat, E.
Right arrow Articles by Niedermann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Firat, E.
Right arrow Articles by Niedermann, G.

Analysis of Direct and Cross-Presentation of Antigens in TPPII Knockout Mice1

Elke Firat2,*, Jisen Huai2,*, Loredana Saveanu{dagger}, Simone Gaedicke*, Peter Aichele{ddagger}, Klaus Eichmann§, Peter van Endert{dagger} and Gabriele Niedermann3,*

* Clinic for Radiotherapy, University Hospital of Freiburg, Freiburg, Germany; {dagger} Institut National de la Santé et de la Recherche Médicale, Université Paris Descartes, Faculté de Médecine René Descartes, Paris, France; {ddagger} Institute for Medical Microbiology and Hygiene, Department of Immunology, University of Freiburg, Freiburg, Germany; and § Max-Planck Institute of Immunobiology, Freiburg, Germany

Tripeptidyl peptidase II (TPPII) is an oligopeptidase forming giant complexes in the cytosol that have high exo-, but also, endoproteolytic activity. Immunohistochemically, the complexes appear as distinct foci in the cytosol. In part controversial biochemical and functional studies have suggested that TPPII contributes, on the one hand, positively to Ag processing by generating epitope carboxyl termini or by trimming epitope precursors, and, on the other, negatively by destroying potentially antigenic peptides. To clarify which of these roles is predominant, we generated and analyzed TPPII-deficient mice. Cell surface levels of MHC class I peptide complexes tended to be increased on most cell types of these mice. Although presentation of three individual epitopes derived from lymphocytic choriomeningitis virus was not elevated on TPPII–/– cells, that of the immunodominant OVA epitope SIINFEKL was significantly enhanced. Consistent with this, degradation of a synthetic peptide corresponding to the OVA epitope and of another corresponding to a precursor thereof, both being proteasomally generated OVA fragments, was delayed in TPPII-deficient cytosolic extracts. In addition, dendritic cell cross-presentation of phagocytosed OVA and of OVA internalized as an immune complex was increased to about the same level as direct presentation of the Ag. The data suggest a moderate, predominantly destructive role of TPPII in class I Ag processing, in line with our finding that TPPII is not induced by IFN-{gamma}, which up-regulates numerous, predominantly constructive components of the Ag processing and presentation machinery.

1 This work was supported by the Deutsche Forschungsgemeinschaft (NI 368/4–2), the Clotten Foundation, and a grant from the Forschungskommission of the University of Freiburg Medical Faculty (NIE346/04).

2 E.F. and J.H. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Gabriele Niedermann, Clinic for Radiotherapy, University Hospital of D-79106 Freiburg, Freiburg, Germany. E-mail address: gabriele.niedermann{at}uniklinik-freiburg.de

4 Abbreviations used in this paper: ER, endoplasmic reticulum; Ct, C-terminal; ERAP, endoplasmic reticulum-associated aminopeptidase; LAP, leucine aminopeptidase; TOP, thimet oligopeptidase; PSA, puromycin sensitive aminopeptidase; TPPII, tripeptidyl peptidase II; KO, knockout; AAF-CMK alanine-alanine-phenylalanine-chloromethyl ketone; DCs, dendritic cells; BM, bone marrow; LCMV, lymphocytic choriomeningitis virus; VV, vaccinia virus; ID, immunodominant; WT, wild type.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Huai, E. Firat, A. Nil, D. Million, S. Gaedicke, B. Kanzler, M. Freudenberg, P. van Endert, G. Kohler, H. L. Pahl, et al.
Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice
PNAS, April 1, 2008; 105(13): 5177 - 5182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.